TipRanks
Go Ultimate55% OFF

Align Tech (ALGN) AI Stock Analysis

MX:ALGN

Align Tech

(BMV:ALGN)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Very low leverageAlign’s exceptionally low leverage and growing equity base provide substantial financial resilience and flexibility. The conservative balance sheet can support investment in digital workflows, innovation, and capital returns while reducing exposure to refinancing pressure during weaker demand periods.
Negative Factors
Persistent ASP pressureFalling average selling prices can limit revenue and profit growth even when case volumes increase. The pressure is linked to geographic and product mix and higher discounts, while management expects ASP to remain slightly lower, making mix improvement important to future earnings.

Align Tech (ALGN) vs. SPDR S&P 500 ETF (SPY)

-10%0%10%20%30%40%MX:ALGN-0.99%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
MXN 10.65B
Dividend Yield
―
Average Volume (3M)
50
Price to Earnings (P/E)
21.8
Beta (1Y)
-0.11
Revenue Growth
-6.35%
EPS Growth
19.16%
Country
Mexico
Employees
20,290
Sector
Healthcare
Sector Strength
51
Industry
Medical - Devices

Align Tech Business Overview & Revenue Model

Company Description

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wid...

Align Tech Earnings Call Summary

Earnings Call Date:Oct 27, 2026(Q3-2026)|% Change Since:0.00%|Next Earnings Date:Feb 02, 2027
Earnings Call SentimentPositive

The call was positive overall. Align reported record Clear Aligner shipments and doctor submitters, broad international growth, improved utilization, stronger operating margins, healthy cash generation and continued investment in digital workflows and 3D-printing innovation. These strengths outweighed the lowlights, which included a challenging consumer environment, lower Systems and Services revenue, ASP and mix pressure, North American GP retail weakness, foreign exchange effects and reduced fourth-quarter revenue assumptions.

Positive Updates

Record Clear Aligner Shipments and Doctor Submitters
Third-quarter worldwide revenue was $1.015 billion, up 1.9% year-over-year or 2.4% at constant currency and in line with outlook. Clear Aligner shipments increased 6.6% to a record 691,000, at the high end of the expected mid-single-digit growth range. A record 91,000 doctors submitted Invisalign cases, up more than 3% year-over-year, while overall utilization increased 3.4%.

Negative Updates

Systems and Services Revenue Decline
Q3 Systems and Services revenue was $175.5 million, down 7.6% year-over-year or 7.1% at constant currency. Reported revenue reflected a greater mix of lower-priced scanner configurations and flexible acquisition models, including leasing, financing, rentals and certified preowned systems.

Company Guidance

For Q4 2026, assuming no circumstances occur beyond our control that could impact our business, Align expects worldwide revenues in the range of $1 billion to $1.020 billion, Clear Aligner volume to be up low single digits year-over-year, Clear Aligner ASP to be down approximately 1% year-over-year, Systems and Services revenue in the range of $170 million to $180 million, GAAP gross margin of approximately 71%, non-GAAP gross margin of approximately 72%, GAAP operating margin of approximately 20%, non-GAAP operating margin of approximately 26%, and to repurchase up to $300 million of common stock; for fiscal 2026, it expects worldwide revenue of approximately $4.11 billion to $4.13 billion, Clear Aligner volume and revenue growth up approximately 5% to 6% year-over-year, Clear Aligner ASP slightly below 2025, Systems and Services revenue of $715 million to $725 million, GAAP operating margin of approximately 16.2%, up approximately 2.7 points year-over-year, non-GAAP operating margin of approximately 23.7%, representing approximately 100 basis point improvement year-over-year, capital expenditures of approximately $125 million to $150 million, and approximately $500 million of common-stock repurchases; for 2027, Align expects another year of revenue growth and margin expansion, continued Invisalign volume growth, record doctor submitters, improving utilization, a broadly stable Clear Aligner pricing environment with ASP slightly down, Systems and Services revenue growth with solid unit growth and stable ASPs, and at least another 100 basis points of non-GAAP operating margin improvement, with preliminary planning assuming an operating environment broadly consistent with current conditions and not requiring a consumer recovery.

Align Tech Risk Analysis

Align Tech disclosed 37 risk factors in its most recent earnings report. Align Tech reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

1 New Risk
1.Our business could be negatively impacted as a result of shareholder activism.Q1, 2026

Align Tech Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

MX:ALGN against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
INMDINMD75Outperform$760.73M10.5811.80%―-6.71%-50.25%
GEHCGEHC71Outperform$34.62B19.8416.13%0.19%6.87%-2.26%
PHGPHG69Neutral$26.31B20.7210.05%3.68%――
BFLYBFLY67Neutral$1.70B-30.52-28.22%―39.35%38.09%
VREXVREX57Neutral$782.60M35.104.60%―5.31%―
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%

* Healthcare Sector Average

Performance Comparison

0%100%200%MX:ALGNPHGVREXINMDBFLYGEHCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
MX:ALGN and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:ALGNAlign Technology2500.00-25.00-0.99%
PHGKoninklijke Philips N.V.26.920.582.19%
VREXVarex Imaging Corporation18.436.3953.07%
INMDInmode13.22-1.47-10.01%
BFLYButterfly Network, Inc.6.393.48119.59%
GEHCGe Healthcare Technologies Inc.76.572.253.03%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.